Skip to main content

Diarrhea clinical trials at UCLA

1 research study open to eligible people

Showing trials for
  • Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

    open to eligible people ages 18 years and up

    The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory dose response of paltusotine treatment in subjects with carcinoid syndrome. This study consists of a Randomized Treatment Phase followed by an Open-Label Extension (OLE) Phase.

    Los Angeles, California and other locations

Last updated: